Publicité
Publicité
SLNO
Soleno Therapeutics, Inc. Common Stock
43.00
USDSponsorisé
-2.52
-5.53%
09 janv., 15:59 UTC -5
Fermé
Pré-marché
43.46
+0.46
+1.07%
SLNO Rapports sur les bénéfices
Ratio de surprise positive
SLNO a dépassé 21 des 39 dernières estimations.
54%
Prochain rapport
Date du prochain rapport
25 févr. 2026
Estimate for Q4 25 (Revenue/ EPS)
$83.34M
/$0.56
Variation implicite de Q3 25 (Revenue/ EPS)
+26.24%
/+19.15%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-144.09%
Soleno Therapeutics, Inc. Common Stock earnings per share and revenue
On 04 nov. 2025, SLNO reported earnings of 0.47 USD per share (EPS) for Q3 25, beating the estimate of 0.05 USD, resulting in a 759.23% surprise. Revenue reached 66.02 million, compared to an expected 49.06 million, with a 34.58% difference. The market reacted with a -26.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analystes forecast an EPS of 0.56 USD, with revenue projected to reach 83.34 million USD, implying an hausse of 19.15% EPS, and hausse of 26.24% in Revenue from the last quarter.
FAQ
What were Soleno Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Soleno Therapeutics, Inc. Common Stock reported EPS of $0.47, beating estimates by 759.23%, and revenue of $66.02M, 34.58% above expectations.
How did the market react to Soleno Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -26.59%, changed from $63.85 before the earnings release to $46.87 the day after.
When is Soleno Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 févr. 2026.
What are the forecasts for Soleno Therapeutics, Inc. Common Stock's next earnings report?
Based on 15
analystes, Soleno Therapeutics, Inc. Common Stock is expected to report EPS of $0.56 and revenue of $83.34M for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité